Global Health Exhibition Briefing: Analysis of U.S. Healthcare Investment in Saudi Arabia

October 22, 2024

Riyadh

On October 22, AmCham Saudi Arabia's Healthcare Committee, in partnership with the U.S. Chamber of Commerce, hosted a breakfast at Global Health Exhibition to launch the report titled "Analysis of U.S. Healthcare Investments in Saudi Arabia." Commissioned by Euromonitor International, this insightful report examines the economic impact of U.S. investments in the Kingdom’s healthcare system.

The event featured a presentation by Ram Kumar, Consulting Manager - MENA at Euromonitor International, along with welcome remarks from Mazen Takhah, Chair of the AmCham Saudi Arabia Healthcare Committee and Senior Director for Government Affairs and Policy MENA at Johnson & Johnson, and Liz Clark, Executive Director for the U.S.-Saudi Arabia Business Program at U.S. Chamber of Commerce. Additionally, attendees heard from Khaled Sehly, Program Director of the AmCham Saudi Arabia Healthcare Committee and Market Access & Government Affairs Lead for Middle East Africa at Bristol Myers Squibb.

Industry leaders from platinum sponsors Abbott, Amgen, and Johnson & Johnson, along with other esteemed sponsors DaVita KSA, MSD, Oracle, Biogen, and Gilead Sciences, discussed the crucial role of U.S. companies in shaping the Saudi healthcare landscape.

U.S. Ambassador to Saudi Arabia, Michael Ratney, and H.E. Dr. Hisham bin Saad Aljadhey, CEO of SFDA, were also in attendance, reinforcing the significance of healthcare sector in strengthening U.S.-Saudi relations.

Key insights were shared by our speakers:

- Mazen Takhah stated: “Today’s briefing on U.S. Healthcare Investments in Saudi Arabia underscores AmCham's commitment to enhancing healthcare quality and fostering collaboration between American and Saudi entities. The robust research by Euromonitor highlights our invaluable partnership, which will strengthen as we work together more closely in the coming years.”

- Khaled Sehly remarked: “This whitepaper provides clear, evidence-based insights into the significant strides we’ve made in advancing Saudi Arabia’s already strong healthcare system. Public-private partnerships are no longer just plans; they are actions in motion, growing with impressive momentum.”

- Liz Clark added: “The healthcare industry is a cornerstone of the global economy, and U.S. companies are a significant part of the transformative story behind Saudi Arabia’s healthcare ecosystem. This partnership promises to grow exponentially.”

This report reveals the transformative impact of partnerships and showcases over SAR 50 billion in cumulative U.S. investment in the past decade to enhance Saudi Arabia's healthcare capabilities.

Read the full report here: U.S. Healthcare Investment in Saudi Arabia

Photos and Video: Global Health Exhibition Briefing: Analysis of U.S. Healthcare Investment in Saudi Arabia  - AmChamKSA - Google Drive